Medical/Pharmaceuticals

New SEMI-NBMC, GE Research Project to Advance Vital Signs Monitoring of Patients During Emergency Air Transport

MILPITAS, California, June 22, 2020 /PRNewswire/ -- Nano-Bio Materials Consortium (NBMC), a SEMI Strategic Association Partner, today launched a project with GE Research to develop a medical-grade wireless patch that monitors the vital signs of medical patients during emergency air transport. Th...

2020-06-22 22:00 1436

WAT Medical Delivers 650,000 Digital Thermometers to Canadian Customers

VANCOUVER, BC, June 22, 2020 /PRNewswire/ -- WAT Medical received an order for 650,000 digital thermometers from partners inCanada earlier this year. As of June, WAT Medical has finished manufacturing and delivering all of the requested units in a timely manner, while satisfying all of the specif...

2020-06-22 21:00 1223

Arçelik Completes Mass Production of 5,000 Ventilators to Meet International Demand

- Arçelik, which owns Beko and Grundig, collaborated with leading Turkish businesses to produce the life-saving ventilators on a not-for-profit basis - Ventilators have been provided to countries including Brazil, Chad, Nigeria, Niger, Azerbaijan, Libya, Uzbekistan, Somalia, Dagestan and Syria - ...

2020-06-22 16:00 2626

Cutting-edge Multidisciplinary Approaches to Minimally Invasive Cancer Treatment Utilizing JCI MN COLLOIDAL IODINE (R) and Possible Effect on SARS-CoV-2

TOKYO, June 22, 2020 /PRNewswire/ -- On June 10, 2020, JCI MN IODINE Co., Ltd. released the following new information regarding the therapeutic usefulness of JCI MN IODINE agents.Ryusuke Fujiki, Clinical Head and President of Fujiki Hospital, announced "minimally invasive, multidisciplinary treat...

2020-06-22 13:00 1058

Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs

SYDNEY, June  22, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share poster presentations of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most com...

2020-06-22 12:39 4144

Qiming's Portfolio Company SinocellTech Lands on STAR Market

SHANGHAI, June 22, 2020 /PRNewswire/ -- Chinese biologic drug developer SinocellTech, Qiming's portfolio company, today lands on the Science and Technology Innovation Board (the STAR Market). The issue price of SinocellTech (SHSE: 688520) isCNY 25.64 per share. The stock opens at CNY 85 per share...

2020-06-22 12:20 2445

Amid Turmoil, 2020 Tang Prize Laureates Strive for An Orderly New World

TAIPEI, June 22, 2020 /PRNewswire/ -- The theme of the 2020 Tang Prize, "for a world of virtue," is intended to extol the pursuit of the ultimate goodness taken up by its latest laureates who demonstrated to us the best one can achieve in the fields of environmental sustainability, medical scienc...

2020-06-22 08:09 1833

Innovent Announces The Stock Exchange of Hong Kong Limited Approved the "B" Marker Removal from the Company's Stock Symbol in the HKEX

SUZHOU, China, June 22, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announc...

2020-06-22 07:40 6158

Ascentage Pharma Enters Clinical Collaboration to Evaluate the Combination of Bcl-2 and BTK Inhibitors

SUZHOU, China and ROCKVILLE, Md., June 22, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and senescence diseases, today announced a clinical collaboration with Acerta P...

2020-06-22 07:15 2927

Amid Turmoil, 2020 Tang Prize Laureates Strive for An Orderly New World

TAIPEI, Taiwan, June 21, 2020 /PRNewswire/ -- The theme of the 2020 Tang Prize, "for a world of virtue," is intended to extol the pursuit of the ultimate goodness taken up by its latest laureates who demonstrated to us the best one can achieve in the fields of environmental sustainability, medica...

2020-06-21 12:30 1461

Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China

SUZHOU, China, June 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announc...

2020-06-19 12:20 10947

Reistone Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata

SHANGHAI, June 18, 2020 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone), a clinical stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory diseases, today announced dosing of the first patient in their Phase II, global clinical trial (R...

2020-06-19 09:16 1242

VISTA Eye Specialists collaborates with Hoya Vision Care and Vision Space Optometrists to raise awareness on Myopia Pandemic[1]

KUALA LUMPUR, Malaysia, June 19, 2020 /PRNewswire/ -- VISTA, in a collaboration with Hoya Vision Care and Vision Space Optometrists (Vision Space), will be sharing with the public, via Facebook Live Webinar on25 June 2020 8pm titled 'Addressing our Children's Sight: Controlling the progress of Sh...

2020-06-19 08:30 3427

Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing

AGC Biologics produces humanized monoclonal antibody targeting IL-15 SEATTLE, June 18, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch of CALY-002 forCalypso Biotech. The immunotherapy biot...

2020-06-18 19:00 2520

Ascentage Pharma Submits Its First New Drug Application to National Medical Products Administration, for HQP1351, the First Third-Generation BCR-ABL Inhibitor in China

SUZHOU, China and ROCKVILLE, Md., June 18, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that Guangzhou Healthquest P...

2020-06-18 17:30 2214

Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China

SUZHOU, China, June 18, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today annou...

2020-06-18 12:00 5138

Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Market

SEOUL, South Korea, June 18, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export COVID-19 Test Kits to the Global Market. Leveraging Yuyu Pharma's global network, the company is in...

2020-06-18 09:00 5929

BARDA and Ortho Collaborate to Advance Development of High Specificity SARS-CoV-2 Antibody Tests

RARITAN, New Jersey, June 17, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it is collaborating with Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness an...

2020-06-17 21:54 1538

IONpath appoints Brad Nelson to its leadership team as Senior Vice President of Marketing and Corporate Strategy

MENLO PARK, California, June 17, 2020 /PRNewswire/ -- IONpath, Inc. the leader in multiplexed spatial tissue imaging and analysis, today announced the appointment ofBrad Nelson to the position of Senior Vice President of Marketing and Corporate Strategy. Mr. Nelson will lead marketing, product ma...

2020-06-17 21:07 3423

Kangpu to Present Two Posters at the 2020 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI, June 17, 2020 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company focused on the discovery and development of next-generation of immunomodulatory small molecules for the treatments of solid tumors, hematological malignancies, auto-immune diseases as well as inflammatory...

2020-06-17 21:00 1637
1 ... 555556557558559560561 ... 608